Issue 20, 2024, Issue in Progress
From the journal:

RSC Advances

Retraction: Salidroside enhances the anti-cancerous effect of imatinib on human acute monocytic leukemia via the induction of autophagy-related apoptosis through AMPK activation

Chiyu Ge,a   Junli Zhang*a  and  Feng Fenga  

* Corresponding authors

a School of Pharmacy, Jiangsu Food and Pharmaceutical Science College, Meicheng Road No. 4, Huaian City, Jiangsu Province, P. R. China
E-mail: zhangjunlijl@sina.com

Abstract

Retraction of ‘Salidroside enhances the anti-cancerous effect of imatinib on human acute monocytic leukemia via the induction of autophagy-related apoptosis through AMPK activation’ by Chiyu Ge et al., RSC Adv., 2019, 9, 25022–25033, https://doi.org/10.1039/C9RA01683J.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D4RA90050B
Article type
Retraction
Submitted
23 Apr 2024
Accepted
23 Apr 2024
First published
29 Apr 2024
This article is Open Access
Creative Commons BY license

RSC Adv., 2024,14, 13957-13957

Permissions

Request permissions

Retraction: Salidroside enhances the anti-cancerous effect of imatinib on human acute monocytic leukemia via the induction of autophagy-related apoptosis through AMPK activation

C. Ge, J. Zhang and F. Feng, RSC Adv., 2024, 14, 13957 DOI: 10.1039/D4RA90050B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements